Simplex Trading’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.4K Buy
3,900
+2,500
+179% +$9.34K ﹤0.01% 7031
2025
Q4
$4.9K Buy
+1,400
New +$4.88K ﹤0.01% 7441
2025
Q2
Sell
-1,000
Closed -$1K 8560
2025
Q1
$1K Sell
1,000
-4,500
-82% -$6.2K ﹤0.01% 8137
2024
Q4
$8K Buy
+5,500
New +$7.69K ﹤0.01% 7302
2023
Q3
Sell
-700
Closed -$3K 8591
2023
Q2
$3K Buy
+700
New +$3.55K ﹤0.01% 8170
2021
Q2
Sell
-290
Closed -$280K 9978
2021
Q1
$280K Buy
+290
New +$2.9K ﹤0.01% 4223

Other funds holding APYX

Simplex Trading's APYX Position: Q1 2026 in Review

Simplex Trading reduced its Apyx Medical (APYX) stake by 26% in Q1 2026, selling an estimated $9.5K and leaving 7,392 shares worth $27.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6485.

Simplex Trading first reported a position in APYX in Q3 2018 and has held it in 23 quarters since. The position peaked at $179K in Q4 2018. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Simplex Trading held 7,392 shares of Apyx Medical worth $27.3K as of Q1 2026.
  • Simplex Trading sold 2,542 Apyx Medical shares in Q1 2026, an estimated $9.5K.
  • Apyx Medical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6485 holding.
  • Simplex Trading first reported a position in Apyx Medical in Q3 2018 and has held it in 23 quarters since.
  • Simplex Trading's Apyx Medical position peaked at $179K in Q4 2018.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.